On September 8, 2014, the Drug Enforcement Agency ("DEA") announced aggregate production quotas for Schedules I and II controlled substances and List I chemicals manufactured in 2015. The production limits will increase for several painkillers, including oxymorphone (for conversion), ephedrine (for sale), and cocaine. Ten other drugs will see their quotas decrease. DEA updates the production quotas every year, which determines how much of a controlled substance will be available for national medical, scientific, and industrial use.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
